RiceBran Technologies
Change company Symbol lookup
Select an option...
RIBT RiceBran Technologies
VTNR Vertex Energy Inc
BFI Burgerfi International Inc
ATRO Astronics Corp
BHR Braemar Hotels & Resorts Inc
NBSTU Newbury Street Acquisition Corp
SKX Skechers USA Inc
IGICW International General Insurance Holdings Equity Warrants 17th March 2025 *W EXP 03/17/2025
NHIC Newhold Investment II Corp
MMI Marcus & Millichap Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Consumer Staples : Food Products | Small Cap Value
Company profile

RiceBran Technologies is a specialty ingredient company that is focused on milling rice and other small grains and producing, processing and marketing healthy, natural and nutrient dense products. The Company is engaged in converting raw rice bran into stabilized rice bran (SRB) and value derivative products including: RiBalance, which is a rice bran nutritional package derived from further processing of SRB; RiSolubles, which is a nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, which is a protein and fiber rich insoluble derivative of RiBalance, and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. The Company’s products include food ingredients animal nutrition, and rice bran. The food ingredients include meats, cereals, snacks, beverages, baked goods, breading, and batters. The Company's stabilized rice bran is marketed as a feed ingredient in the United States and international animal nutrition markets.

Closing Price
$0.586
Day's Change
-0.0532 (-8.32%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.63
Day's Low
0.55
Volume
(Heavy Day)
Volume:
5,368,295

10-day average volume:
3,354,272
5,368,295

RiceBran Technologies Reports First Quarter 2022 Results

4:20 pm ET April 28, 2022 (Accesswire) Print

TOMBALL, TX / ACCESSWIRE / April 28, 2022 / RiceBran Technologies (NASDAQ:RIBT) (the "Company"), a global leader in the development and manufacture of nutritional and functional ingredients derived from rice and other small and ancient grains for human food, nutraceutical, pet care and equine feed applications, today announced financial results for the first quarter ended March 31, 2022.

Summary Results ($000s)

1Q22

1Q21

% Chg.

Qual

1Q22

4Q21

% Chg.

Qual

Revenue

$10,559

$8,605

23%

Improved

$10,559

$8,043

31%

Improved

Gross Profit (Loss)

$502

$672

(25%)

Declined

$502

$(107)

NM

Improved

SG&A

$1,692

$1,741

(3%)

Declined

$1,692

$1,611

5%

Increased

Operating Loss

($1,190)

($1,076)

11%

Increased

($1,190)

($5,634)

(79%)

Improved

Net Income (Loss)

($1,516)

$591

NM

Increased

($1,516)

($5,404)

(72%)

Improved

Adj. EBITDA (Loss) (non-GAAP)*

($385)

($158)

144%

Increased

($385)

($806)

(52%)

Improved

* Reconciliation of GAAP to Non-GAAP measures follows.

First Quarter 2022 Operating Highlights

"The first quarter's results built upon the momentum we began to see in December and bodes well for the year to come," said RiceBran's Executive Chairman Peter Bradley. "We are aligned with healthy living trends and benefitting from having high quality domestically sourced products in a difficult global supply chain environment. Strong growth in the quarter for our core-SRB and milling businesses reflects improved execution, while plans to introduce new products and expand production should support continued revenue growth and a transition to sustainable profitability, validating our strategic shift to a high value-add specialty ingredients focus."

  • Company delivers strong growth and a return to positive gross profits. Total revenue of $10.6 million in 1Q22, was up 23% from 1Q21, and 31% from 4Q21, driven by higher core-SRB sales and strong growth for MGI and Golden Ridge. Improved results for MGI and Golden Ridge supported a return to gross profits from gross losses in 4Q21, although gross profits of $502,000 in 1Q22 were off from $672,000 a year ago due to lower Value-Add SRB derivative sales. Net losses were $1.5 million in 1Q22, compared to net income of $591,000 in 1Q21, due to a $1.8 million benefit in 1Q21 from the forgiveness of the Company's PPP loan. Adjusted EBITDA losses (non-GAAP) were $385,000 in 1Q22, compared to $158,000 in 1Q21, due to lower gross profits.
  • Positive momentum underpinned by strong demand and improved execution. RiceBran saw meaningful growth for its core-SRB business in 1Q22, driven by stronger customer demand and higher prices. Sales initiatives put into place last year are bearing fruit as customers increasingly turn to SRB from alternative ingredients, which are becoming progressively more expensive and more difficult to source reliably. MGI and Golden Ridge are similarly benefiting from higher demand for domestically sourced agricultural ingredients and generated strong revenue growth and improved profitability in 1Q22, both year-over-year and sequentially, supported by improved execution from the RiceBran team.
  • Value-Add to offer upside to revenue and profits in coming quarters. Strong results in 1Q22 occurred despite lower sales and associated contribution margin from Value-Add SRB derivatives due to the timing of large customer orders and a tough year-over-year comparison. Results are expected to reaccelerate in the coming quarters due to strong demand, enhanced supply chain sourcing, and increased production capacity. Management is confident in its strategy of transitioning the Company to a higher value-add specialty ingredients focus and looks for stronger gains from this business in the second half of the year, supported by new product introduction and higher sales from the Company's distribution partnership with AIDP.
  • New directors to support shift to value-add ingredient strategy. RiceBran is pleased to announce that Jean Heggie and Will Black have joined the Company's Board of Directors effective today, replacing Ari Gendason and Beth Bronner who have resigned effective today. Ms. Heggie and Mr. Black each have over 30 years of experience in the consumer food ingredient, ag-tech, and global health and nutrition industries. With their extensive relationships and experience developing consumer-oriented foods and food ingredients, Mr. Black and Ms. Heggie are well-positioned to help the Company accelerate its strategic shift to a specialty ingredient company.

"With their relevant consumer-facing food ingredient, ag-tech, and health and nutrition expertise, the addition of Ms. Heggie and Mr. Black to our Board signals the next important step in our strategic shift to a high value-add provider of specialty ingredients," said Executive Chairman Peter Bradley. "Both Ms. Heggie and Mr. Black have extensive experience developing and commercializing new products for companion animal and human end-markets, and as we introduce new products and expand the use of stabilized rice bran as an alternative to less healthy alternatives, we expect to be able to draw from their knowledge base to more rapidly penetrate new customers and accelerate growth of higher value-add ingredients We also thank Ari and Beth for their many contributions to the Company as we transformed the organization. Their guidance was invaluable during this process, and their oversight has been important in enabling us to reach this inflection point."

First Quarter 2022 Financial Highlights

  • Revenue momentum remained strong in the first quarter. Total revenue was $10.6 million in 1Q22, up 23% from $8.6 million in 1Q21, and up 31% from $8.0 million in 4Q21. Strong year-over-year and sequential revenue growth in 1Q22 reflected higher core-SRB sales and strong results for both MGI and Golden Ridge, while Value-Add SRB derivative sales were unchanged from 4Q21 levels, but off against a tough comparison in 1Q21.
  • Company returned to positive gross profit margins. Gross profit was $502,000 in 1Q22, up from gross losses of $107,000 in 4Q21, with margin improvement supported by higher volumes and price increases for core-SRB sales, and strong results for both MGI and Golden Ridge. Gross profit declined from $672,000 in 1Q21 due to the year-over-year decline in higher-margin Value-Add SRB derivative sales.
  • Quarterly SG&A remains stable under $1.7 million. SG&A declined 3% year-over-year, which was less than the decline in gross profit. As a result, operating loss increased modestly to $1.2 million in 1Q22 from losses of $1.1 million in 1Q21. Net loss was $1.5 million, or ($0.03) per share, in 1Q22 versus net income of $591,000, or $0.01 per share, in 1Q21 due to a $1.8 million benefit in the prior period from the forgiveness of the Company's SBA PPP loan.
  • Adjusted EBITDA (non-GAAP*) losses were $385,000. The Company continued its recent trend of quarterly improvements in cash flow. Adjusted EBITDAlosses (non-GAAP) were $385,000 in 1Q22, down from adjusted EBITDA losses (non-GAAP) $806,000 in 4Q21, driven by higher revenue and the transition to positive gross profits, but off from adjusted EBITDA losses (non-GAAP) of $158,000 in 1Q21 due to lower sales of higher margin Value-Add SRB derivatives.
  • Balance sheet strengthened with sufficient liquidity. Total cash grew to $5.9 million at the end of 1Q22 from $5.8 million at the end of 4Q21, driven by positive operating cash flow, lower capital expenditures, and an increase in short-term borrowing from the Company's factoring facility. Management continues to believe that the Company has sufficient cash reserves to bridge the gap to positive adjusted EBITDA.

RiceBran's CFO Todd Mitchell commented, "The Company's strong top line growth and transition to gross profit, despite facing a difficult comparison in our Value-Add SRB derivative business, reflect a healthy demand environment and strong execution from everyone on the RiceBran team and further validation of the Company's strategic shift to a value-add specialty ingredient focus. We still look for future improvement in our core-SRB business in the coming quarters, which with an expected return to growth from our Value-Add SRB derivatives business, should drive gross margins higher and allow the Company to transition to positive adjusted EBITDA."

Conference Call Information

RiceBran Technologies will host a conference call today, Thursday, April 28, at 4:30 p.m. Eastern Time to discuss these results. The call information is as follows:

  • Date: April 28, 2022
  • Time: 4:30 p.m. Eastern Standard Time
  • Toll Free Dial-in number for US/Canada: 877-545-0320
  • Dial-In number for international callers: 973-528-0002
  • Participant Access Code: 857215
  • Webcast: https://www.ricebrantech.com/investors

Following the conclusion of the live call, a replay of the webcast will be available on the Investor Relations section of the Company's website for at least 90 days. A telephonic replay of the conference call will also be available from 7 p.m. EST on April 28, 2022 until 11:59 p.m. EST on May 12, 2022 by dialing 877-481-4010 (United States) or 919-882-2331 (international) and using the passcode 45277.

About RiceBran Technologies

RiceBran Technologies is a specialty ingredient company focused on the development, production, and marketing of products derived from traditional and ancient small grains. Notably, we are global leader in the production and marketing of stabilized rice bran (SRB), and high value-added derivative products derived from SRB, as well as a processor of rice, rice co-products, and barley and oat products. We create and produce products utilizing proprietary processes to deliver improved nutrition, ease of use, and extended shelf-life, while addressing consumer demand for all natural, non-GMO and organic products. The target markets for our products include food and animal nutrition manufacturers and retailers, as well as specialty food, functional food and nutritional supplement manufacturers and retailers, both domestically and internationally. More information can be found in the Company's filings with the SEC and by visiting our website at http://www.ricebrantech.com.

Forward-Looking Statements

This release contains forward-looking statements, including, but not limited to, statements about RiceBran's expectations regarding its future financial results, sales growth, adjusted EBITDA (non-GAAP) improvements, and SG&A. These statements are made based upon current expectations that are subject to known and unknown risks and uncertainties, including the risks that operations are disrupted by the COVID-19 pandemic and timing of profitable operations. RiceBran Technologies does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in RiceBran Technologies' filings with the Securities and Exchange Commission, including its most recent periodic reports.

Use of Non-GAAP Financial Information

We utilize "adjusted EBITDA" "Net Cash" and "Net Debt" as supplemental measures in our ongoing analysis of short term and long-term cash requirement and liquidity needs. Management uses adjusted EBITDA as an indicator of our current financial performance. By eliminating the impact of all material non-cash charges as well as items that do not regularly occur, we believe that adjusted EBITDA provides a more accurate and informative indicator of our cash requirements. Adjusted EBITDA does not represent cash flows from operations as defined by generally accepted accounting principles ("GAAP"), is not a measure derived in accordance with GAAP and should not be considered as an alternative to net income (the most comparable GAAP financial measure to adjusted EBITDA).

The tables below contain a reconciliation of net loss (GAAP) and adjusted EBITDA (non-GAAP) for the three months ended March 31, 2022 and March 31, 2021, and for Net Cash (non-GAAP) and Net Debt (non-GAAP) for the periods ended March 31, 2022 and December 31, 2021. We do not provide a reconciliation of forward-looking net loss (GAAP) to adjusted EBITDA (non-GAAP). Due to the nature of certain reconciling items, it is not possible to predict with any reliability what future outcomes may be with regard to the expense or income that may ultimately be recognized in future periods. Any forward-looking adjusted EBITDA information that we may provide from time to time consistently excludes the same items from projected net loss that are excluded from actual net loss in the table below.

Investor Contact

Rob Fink / Matt Chesler, CFA

FNK IR

ribt@fnkir.com

646.809.4048 / 646.809.2183

RiceBran Technologies

Consolidated Income Statement (Unaudited) (GAAP)

(in $000, except per share amounts)

3 Months Ended
3/31/223/31/21% Chg.

Revenue

$10,559$8,60523%

Cost of Goods Sold

(10,057)(7,933)27%

Gross Profit

502672(25%)

Gross Margin

58

Selling, General & Admin.

(1,692)(1,741)(3%)

Loss on PP&E

-(7)NM

Operating Loss

(1,190)(1,076)11%

Interest Expense, net

(125)(111)13%

Gain on Extinguishment of PPP loan

-1,792NM

Change in FV of Derivative Warrant Liability

(171)-NM

Other Expense, net

(30)(13)131%

Income (Loss) Before Income Taxes

(1,516)592NM

Income Taxes

-(1)NM

Net Income (Loss)

$(1,516)$591NM

Basic & Diluted Earnings (Loss) per Share:

$(0.03)$0.01NM

Weighted Avg. Shares Outstanding (Basic & Diluted):

52,53045,63515%

RiceBran Technologies

EBITDA and Adjusted EBITDA Reconciliation (Unaudited) (Non-GAAP)

(in $000)

3 Months Ended
3/31/223/31/21% Chg.

Net Income (Loss)

$(1,516)$591NM

Interest Expense

12511113%

Income Taxes

-1

Depreciation and Amortization

559665(16%)

EBITDA

$(832)$1,368NM

Gain on extinguishment of PPP loan

-(1,792)NM

Change in FV of Derivative Warrant Liability

171-NM

Other Expense

3013131%

Share-Based Compensation

246253(3%)

Adjusted EBITDA

$(385)-$(158)144%

RiceBran Technologies

Consolidated Statement of Cash Flows (Unaudited)

(in $000)

3 Months Ended

3/31/223/31/21% Chg.

Cash Flow from Operations

Net Income (Loss)

$(1,516)$591NM

Adjs. to reconcile net Income (Loss) to net cash

provided by (used in) operating activities:

Depreciation

516612(16%)

Amortization

4353(19%)

Share-Based Compensation

246253(3%)

Gain on Extinguishment of PPP Debt

-(1,792)NM

Change in FV of Derivative Warrant Liability

171-NM

Other

(48)(18)167%

Changes in operating assets and liabilities:

NM

Accounts Receivable

(493)(808)(39%)

Inventories

(39)384NM

Accounts Payable

88450874%

Commodities Payable

5895566%

Other

(163)(340)(52%)

Net Cash Flow from Operations

$190$(1)NM

Cash Flow from Investing

Purchases of PP&E

(157)(325)(52%)

Proceeds from Insurance on Involuntary Conversion

109-NM

Net Cash Flow from Investing

$(48)$(325)(85%)

Cash Flow from Financing

Net Change in Debt

(99)481NM

Net Cash Flow from Financing

$(99)$481NM

Net Change in Cash

$43$155NM

BOP Cash Balance

$5,825$5,263

Net Change in Cash

43155

EOP Cash Balance

$5,868$5,418

RiceBran Technologies

Consolidated Balance Sheets (Unaudited)

(in $000)

Period Ending
3/31/2212/31/21% Chg.

Assets

Cash and Cash Equivalents

$5,868$5,8251%

Accounts Receivable, net

4,6294,13612%

Inventories

2,4822,4442%

Other Current Assets

95281018%

Total Current Assets

$13,931$13,2155%

PP&E, Net

14,88715,444(4%)

Operating Lease right-of-use assets

2,0432,127(4%)

Goodwill & Intangibles

484527(8%)

Total Assets

$31,345$31,3130%

Liabilities and Shareholders' Equity

Accounts Payable

$1,672$826102%

Commodities Payable

2,2911,70235%

Accruals

1,3971,470(5%)

Leases, Current

4784682%

Debt, Current

4,9384,6905%

Total Current Liabilities

$10,776$9,15618%

Leases, Not Current

1,8802,048(8%)

Debt, Not Current

1,0351,356(24%)

Derivative Warrant Liability

42925866%

Total Liabilities

$14,120$12,81810%

Preferred Stock

7575NM

Common Stock

326,525326,2790%

Accumulated Deficit

(309,375)(307,859)0%

Total Shareholders' Equity

$17,225$18,495(7%)

Total Liabilities and Shareholders' Equity

$31,345$31,3130%

RiceBran Technologies

Net Cash and Net Debt Reconciliation (Unaudited) (Non-GAAP)

(in $000)

Period Ending
3/31/2212/31/21% Chg.

Cash and Cash Equivalents

$5,868$5,8251%

Less: Total Debt, Current and Non-current

5,9736,046(1%)

Net Cash (Debt)

$(105)$(221)(52%)

SOURCE: RiceBran Technologies





View source version on accesswire.com:

https://www.accesswire.com/699312/RiceBran-Technologies-Reports-First-Quarter-2022-Results



comtex tracking

COMTEX_406404490/2457/2022-04-28T16:20:27

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.